Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Transplant International : Official Journal of the European Society for Organ Transplantation|August 19, 2015
Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantationPhilippe Gatault, Dominique Bertrand, Matthias Büchler, et al.
Frontiers in Immunology|December 28, 2020
Deciphering the Prognostic and Predictive Value of Urinary CXCL10 in Kidney Recipients With BK Virus ReactivationClaire Tinel, Agathe Vermorel, Daniela Picciotto, et al.
Kidney International|May 26, 2026
Optimizing risk-benefit in highly sensitized kidney recipient antigen delisting increasing donor accessCédric Usureau, Jérémy Siemowski, Dany Anglicheau, et al.
Transplantation|January 24, 2017
Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant ProgramLucile Amrouche, Olivier Aubert, Caroline Suberbielle, et al.
Journal of the American Society of Nephrology : JASN|February 15, 2022
CRISPR/Cas9-Engineered HLA-Deleted Glomerular Endothelial Cells as a Tool to Predict Pathogenic Non-HLA Antibodies in Kidney Transplant RecipientsBaptiste Lamarthée, Carole Burger, Charlotte Leclaire, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 29, 2020
Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejectionClaire Tinel, Arnaud Devresse, Agathe Vermorel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 5, 2019
Baseline graft status is a critical predictor of kidney graft failure after diarrhoeaArnaud Devresse, Lise Morin, Florence Aulagnon, et al.
Nephrologie & Therapeutique|April 18, 2008
[First acute rejection episode after renal transplantation: study of the histopathological characteristics according to the immunological risk]Lidia Ghisdal, Guy Touchard, Jean-Michel Goujon, et al.
Joint Bone Spine|November 10, 2016
Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centersPierre-Antoine Juge, Marie-Elise Truchetet, Evangeline Pillebout, et al.
Pageof 9